Financial Performance - The company's operating revenue for Q3 2023 reached ¥1,092,181,203.37, representing a year-on-year increase of 58.58%[3] - The net profit attributable to shareholders for Q3 2023 was ¥56,966,229.14, showing a slight increase of 3.08% compared to the same period last year[3] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥55,155,794.82, which is an increase of 20.94% year-on-year[3] - The basic earnings per share for Q3 2023 was ¥0.11, a decrease of 21.43% compared to the previous year[4] - Total operating revenue for the first three quarters of 2023 reached CNY 2,532,913,062, a 28.1% increase from CNY 1,975,586,910 in the same period of 2022[17] - Net profit for the first three quarters of 2023 was CNY 149,792,317.69, a decrease of 20.7% compared to CNY 188,958,041.70 in the same period of 2022[18] - Basic and diluted earnings per share for the third quarter of 2023 were CNY 0.32, down from CNY 0.48 in the same quarter of 2022[19] Assets and Liabilities - The total assets at the end of Q3 2023 amounted to ¥4,598,729,118.12, reflecting a growth of 57.95% compared to the end of the previous year[4] - Total current assets reached ¥4,273,854,794.72, up from ¥2,595,114,950.10 in the previous year, indicating a year-over-year increase of 64.7%[14] - The total assets of the company as of September 30, 2023, were ¥4,598,729,118.12, compared to ¥2,911,527,556.07 at the end of 2022, showing a growth of 57.9%[14] - Total liabilities as of the end of Q3 2023 amounted to CNY 1,892,289,064.80, an increase from CNY 1,618,456,165.23 at the end of Q3 2022[16] - Current liabilities reached approximately $1.60 billion, with accounts payable constituting about $1.01 billion[24] - Total liabilities were approximately $1.62 billion, with non-current liabilities accounting for about $21.29 million[25] Shareholder Information - The company reported a total of 57,153 common shareholders at the end of the reporting period[12] - The top shareholder, 柏盈柏诚投资控股（无锡）有限公司, holds 49.76% of the shares, totaling 260,000,000 shares[12] - The company has engaged in financing activities, with several shareholders participating through margin trading accounts, including 北京禧悦私募基金管理有限公司, which holds 305,000 shares[12] Cash Flow and Investments - The company experienced a significant increase in cash outflows due to large project commencements and increased procurement payments[8] - The company reported a net cash flow from operating activities of -¥311,481,287.79 for the year-to-date period, indicating significant cash outflows[3] - Cash inflow from operating activities for the first three quarters of 2023 reached approximately ¥2.07 billion, up from ¥1.84 billion in the same period of 2022, representing an increase of about 12.7%[20] - Net cash flow from operating activities for Q3 2023 was -¥311.48 million, compared to -¥235.45 million in Q3 2022, indicating a worsening cash flow situation[21] - Total cash inflow from financing activities in Q3 2023 was approximately ¥1.48 billion, significantly higher than ¥169.90 million in Q3 2022, showing a substantial increase in financing efforts[21] - The net increase in cash and cash equivalents for Q3 2023 was approximately ¥873.22 million, contrasting with a decrease of -¥177.93 million in Q3 2022, indicating improved liquidity[21] - Cash outflow for investment activities in Q3 2023 totaled approximately ¥211.89 million, compared to ¥166.31 million in Q3 2022, reflecting increased investment expenditures[21] - The company reported a cash balance of approximately ¥1.54 billion at the end of Q3 2023, up from ¥231.34 million at the end of Q3 2022, indicating a strong cash position[21] - The company received approximately ¥70.05 million from investment recoveries in Q3 2023, down from ¥190 million in Q3 2022, highlighting a decline in investment cash inflows[21] - The total cash outflow for operating activities in Q3 2023 was approximately ¥2.39 billion, compared to ¥2.08 billion in Q3 2022, indicating increased operational costs[21] Research and Development - Research and development expenses for the first three quarters of 2023 were CNY 11,572,573.58, compared to CNY 6,324,066.50 in the same period of 2022, reflecting a 83.5% increase[17] Accounting and Standards - The company executed new accounting standards starting January 1, 2023, which may impact financial reporting and asset valuations going forward[22]
柏诚股份(601133) - 2023 Q3 - 季度财报